Concepedia

Author

Idanna Innocenti

Università Cattolica del Sacro CuoreORCID

Also Known As

I Innocenti, I. Innocenti, I.Reyers Degli Innocenti, Idanna Innocenti, Innocenti I

202

Publications

1.6K

Citations

22

H-Index

47

Concepts

All Affiliations

Università Cattolica del Sacro CuoreIstituti di Ricovero e Cura a Carattere ScientificoAgostino Gemelli University PolyclinicFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoCentro di Riferimento Oncologico della Basilicata
II

About

Idanna Innocenti is an author at Università Cattolica del Sacro Cuore specializing in medicine, hematology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

15

322

2

Health Sciences

1

1

17

3

Public Health

1

1

11

4

Allergy

1

1

30

5

Blood Transplantation

1

1

11

Idanna Innocenti

×

34

Publications

974

Citations

19

H-Index

YearCitations

BCR signaling inhibitors differ in their ability to overcome Mcl-1–mediated resistance of CLL B cells to ABT-199

Kamil Bojarczuk, Binu K. Sasi, Stefania Gobessi,

Blood

2016

113

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò,

Leukemia

2021

94

B-cell receptor signaling and genetic lesions in TP53 and CDKN2A/CDKN2B cooperate in Richter transformation

Supriya Chakraborty, Claudio Martines, Fabiola Porro,

Blood

2021

64

CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression

Erika Tissino, Federico Pozzo, Dania Benedetti,

Blood

2020

59

Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia

Luciana De Luca, Giovanni D’Arena, Vittorio Simeon,

Leukemia & lymphoma/Leukemia and lymphoma

2016

51

Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with <scp>anti‐CD19 CAR‐T</scp> cells

Eugenio Galli, Federica Sorà, Stefan Hohaus,

British Journal of Haematology

2022

41

Docosahexaenoic acid reverts resistance to UV-induced apoptosis in human keratinocytes: involvement of COX-2 and HuR

Simona Serini, Valentina Donato, Elisabetta Piccioni,

The Journal of Nutritional Biochemistry

2010

33

Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments

Luca Laurenti, Idanna Innocenti, Francesco Autore,

Leukemia Research

2015

30

Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients

Giovanni D’Arena, Vittorio Simeon, Luca Laurenti,

Leukemia & lymphoma/Leukemia and lymphoma

2017

30

CD200 included in a 4‐marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia

Giovanni D’Arena, Candida Vitale, Giovanni Rossi,

Hematological Oncology

2018

30

Page 1